Developing and Testing Adaptive Treatment Strategies Using Substance-Induced Psychosis as an Example

Name: Developing and Testing Adaptive Treatment Strategies Using Substance-Induced Psychosis as an Example
SKU: 4290
Price: 30.00 USD
Availability: InStock

$30.00

EVIDENCE-BASED MEDICINE

Developing and Testing Adaptive Treatment Strategies Using Substance-Induced Psychosis as an Example

By Ree Dawson, Alan I. Green, Robert E. Drake, Thomas H. McGlashan, Bella Schanzer, Philip W. Lavori

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 41 No. 3 Articles Tags: adaptive-treatment, adaptive-treatment-strategies, alan-i-green, bella-schanzer, experimental-design, philip-w-lavori, ree-dawson, robert-e-drake, substance-induced-psychosis, thomas-h-mcglashan, treatment-strategy

Description

Description

EVIDENCE BASED MEDICINE

Developing and Testing Adaptive Treatment Strategies Using Substance-Induced Psychosis as an Example

By Ree Dawson, Alan I. Green, Robert E. Drake, Thomas H. McGlashan, Bella Schanzer, Philip W. Lavori

PB-41-3-2008-Dawson

Developing and Testing Adaptive Treatment Strategies Using Substance-Induced Psychosis as an Example

Description

Clozapine Related Suicidal Obsession by Branka Aukst-Margetic

Atomoxetine Induced Hypothermia by Onat Yilmaz

Psychometric Evaluation of a Patient-Rated Troubling Symptom Scale for Generalized Anxiety Disorder Clinical Trials

Paliperidone Double-blind, Placebo- and Active-Controlled, Study

Developing and Testing Adaptive Treatment Strategies Using Substance-Induced Psychosis as an Example

Description

Related products

Clozapine Related Suicidal Obsession by Branka Aukst-Margetic

Atomoxetine Induced Hypothermia by Onat Yilmaz

Psychometric Evaluation of a Patient-Rated Troubling Symptom Scale for Generalized Anxiety Disorder Clinical Trials

Paliperidone Double-blind, Placebo- and Active-Controlled, Study